163 related articles for article (PubMed ID: 36987539)
41. Nd:YAG laser treatment of recalcitrant folliculitis decalvans.
Parlette EC; Kroeger N; Ross EV
Dermatol Surg; 2004 Aug; 30(8):1152-4. PubMed ID: 15274709
[TBL] [Abstract][Full Text] [Related]
42. Folliculitis decalvans of the scalp: response to triple therapy with isotretinoin, clindamycin, and prednisolone.
Gemmeke A; Wollina U
Acta Dermatovenerol Alp Pannonica Adriat; 2006 Dec; 15(4):184-6. PubMed ID: 17982613
[TBL] [Abstract][Full Text] [Related]
43. Folliculitis spinulosa decalvans: successful therapy with dapsone.
Kunte C; Loeser C; Wolff H
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 2):891-3. PubMed ID: 9810924
[TBL] [Abstract][Full Text] [Related]
44. Cicatricial alopecia.
Headington JT
Dermatol Clin; 1996 Oct; 14(4):773-82. PubMed ID: 9238335
[TBL] [Abstract][Full Text] [Related]
45. An unusual case of folliculitis spinulosa decalvans.
Fan W; Zhang Q; Song L
Cutis; 2016 Sep; 98(3):175-178. PubMed ID: 27814407
[TBL] [Abstract][Full Text] [Related]
46. Epidermal thickness is useful in distinguishing lichen planopilaris from neutrophil-poor/lymphocyte-predominant folliculitis decalvans.
Bohnett MC; Kolivras A; Thompson AA; Thompson CT
J Cutan Pathol; 2021 Jun; 48(6):816-818. PubMed ID: 33382483
[No Abstract] [Full Text] [Related]
47. Folliculitis spinulosa decalvans: an uncommon entity within the keratosis pilaris atrophicans spectrum.
Di Lernia V; Ricci C
Pediatr Dermatol; 2006; 23(3):255-8. PubMed ID: 16780474
[TBL] [Abstract][Full Text] [Related]
48. Treatment of folliculitis decalvans with tacrolimus ointment.
Bastida J; Valerón-Almazán P; Santana-Molina N; Medina-Gil C; Carretero-Hernández G
Int J Dermatol; 2012 Feb; 51(2):216-20. PubMed ID: 22250634
[TBL] [Abstract][Full Text] [Related]
49. Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum-A Series of 7 New Cases With Focus on Histopathology.
Egger A; Stojadinovic O; Miteva M
Am J Dermatopathol; 2020 Mar; 42(3):173-177. PubMed ID: 31855586
[TBL] [Abstract][Full Text] [Related]
50. Folliculitis Decalvans Has a Heterogeneous Microbiological Signature and Impaired Immunological Response.
Moreno-Arrones OM; Garcia-Hoz C; Del Campo R; Roy G; Saceda-Corralo D; Jimenez-Cauhe J; Ponce-Alonso M; Serrano-Villar S; Jaen P; Paoli J; Vano-Galvan S
Dermatology; 2023; 239(3):454-461. PubMed ID: 36716709
[TBL] [Abstract][Full Text] [Related]
51. Acne keloidalis nuchae and folliculitis decalvans: same process affecting the follicle or coexisting diseases? A retrospective study.
Doche I; Coelho EQ; Quaresma MV; da Matta Rivitti-Machado MC
Int J Dermatol; 2019 Oct; 58(10):e200-e203. PubMed ID: 31241169
[No Abstract] [Full Text] [Related]
52. Folliculitis decalvans with exclusive beard involvement.
Senatore S; Maglie R; Maio V; Montefusco F; Antiga E
Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):569-571. PubMed ID: 33969666
[No Abstract] [Full Text] [Related]
53. Folliculitis decalvans--response to rifampin.
Brozena SJ; Cohen LE; Fenske NA
Cutis; 1988 Dec; 42(6):512-5. PubMed ID: 3229140
[TBL] [Abstract][Full Text] [Related]
54. Folliculitis decalvans responsive to tofacitinib: A case series.
Jerjen R; Meah N; Trindade de Carvalho L; Wall D; Sinclair R
Dermatol Ther; 2020 Nov; 33(6):e13968. PubMed ID: 32623800
[No Abstract] [Full Text] [Related]
55. Tinea capitis mimicking tufted hair folliculitis.
Baroni A; Ruocco E; Aiello FS; Faccenda F; Lo Schiavo A; Satriano RA; Guerrera V
Clin Exp Dermatol; 2009 Dec; 34(8):e699-701. PubMed ID: 19663859
[TBL] [Abstract][Full Text] [Related]
56. Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluation.
Tikhonova IA; Yang H; Bello S; Salmon A; Robinson S; Hemami MR; Dodman S; Kharechko A; Haigh RC; Jani M; McDonald TJ; Hoyle M
Health Technol Assess; 2021 Feb; 25(8):1-248. PubMed ID: 33555998
[TBL] [Abstract][Full Text] [Related]
57. Folliculitis decalvans in women: A retrospective multicentre study of 150 patients.
Sarkis A; Cortez de Almeida RF; Lemes LR; Obadia DL; Machado CJ; Müller-Ramos P; Pedretti M; Starace M; Quadrelli F; Piraccini BM; Alessandrini A; Rossi A; Saceda-Corralo D; Khobzei K; Iorizzo M; Vañó-Galván S; Silyuk T; Tosti A; Vincenzi C; Fechine COC; Anzai A; Rigatti M; Minotto R; D'Atri G; Kakizaki P; Mercau S; Oliveira-Soares R; Navarro Tuculet C; Cappetta ME; Alves LD; Pinto GM; Lima CDS; Frattini S; Melo DF
J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):e66-e70. PubMed ID: 37594799
[No Abstract] [Full Text] [Related]
58. Infections in Patients with Chronic Granulomatous Disease Treated with Tumor Necrosis Factor Alpha Blockers for Inflammatory Complications.
Conrad A; Neven B; Mahlaoui N; Suarez F; Sokol H; Ruemmele FM; Rouzaud C; Moshous D; Lortholary O; Blanche S; Lanternier F
J Clin Immunol; 2021 Jan; 41(1):185-193. PubMed ID: 33150502
[TBL] [Abstract][Full Text] [Related]
59. Clinical and trichoscopic correlation of primary neutrophilic scarring alopecia: folliculitis decalvans and dissecting cellulitis.
Rossi A; Garelli V; Muscianese M; Pranteda G; Caro G; D'Arino A; Fortuna MC
G Ital Dermatol Venereol; 2020 Aug; 155(4):506-508. PubMed ID: 30229638
[No Abstract] [Full Text] [Related]
60. Successful use of infliximab in a patient with recalcitrant folliculitis decalvans.
Mihaljević N; von den Driesch P
J Dtsch Dermatol Ges; 2012 Aug; 10(8):589-90. PubMed ID: 22676386
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
